• Mechanically targeted drug delivery for stroke: moving from clot centric care to collateral therapeutics

Here, drug delivery experts describe a novel shear activated nanoparticle aggregate (NPA) platform that applies precisely targeted stroke therapies using pathological haemodynamics.   

  • Dissolution enhancement via solid-dose delivery of lipid-based formulation 

Tony Carpanzano

JRS Pharma

  • Setting a new standard for Luer Lock syringe closure systems

Daniela Geiger 

Vetter Pharma 

Sponsored by JRS Pharma and Vetter Pharma

View full profile

More JRS Pharma

View full profile

Topics